We added bFGF during the ME induction period, the HE induction period, or both (Fig. 1A), and assessed its impact by analyzing the expression of CD34, CD117, and CD45 as HPC markers in floating cells collected on days 14 and 20 of differentiation. The gene discussed is CD34; the disease is hereditary elliptocytosis.